Cancer surveillance for patients with Li-Fraumeni Syndrome in Brazil: A cost-effectiveness analysis

BACKGROUND: In Brazil, there is a higher prevalence of Li-Fraumeni Syndrome (LFS) compared to worldwide, due to the founder mutation in the TP53 gene p.R337H. However, a large portion of the population, that depends on National Health Care System, does not have access to effective screening through...

Descripción completa

Detalles Bibliográficos
Autores principales: Frankenthal, Isadora A., Alves, Mariana Cartaxo, Tak, Casey, Achatz, Maria Isabel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9904006/
https://www.ncbi.nlm.nih.gov/pubmed/36776423
http://dx.doi.org/10.1016/j.lana.2022.100265

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9904006/
https://www.ncbi.nlm.nih.gov/pubmed/36776423
http://dx.doi.org/10.1016/j.lana.2022.100265

Ejemplares similares